# Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

> **NCT02145104** · PHASE3 · COMPLETED · sponsor: **IlDong Pharmaceutical Co Ltd** · enrollment: 286 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg

## Key facts

- **NCT ID:** NCT02145104
- **Lead sponsor:** IlDong Pharmaceutical Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-17
- **Primary completion:** 2016-06-07
- **Final completion:** 2016-09-29
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2018-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145104, "Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02145104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*